QUOTE AND NEWS
StreetInsider.com  Feb 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/BioTime+%28BTIM%29+Announces+Results+from+Hextrend+in+Hemodynamically+Unstable+Trauma+Patients/5312237.html for the full story.
Business Wire  Feb 5  Comment 
BioTime, Inc. (NYSE Amex:BTIM) today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime’s
Business Wire  Dec 4  Comment 
BioTime, Inc. (NYSE Amex:BTIM) Chief Executive Officer Michael D. West, Ph.D. will ring The Opening Bell at the New York Stock Exchange at 9:30 a.m. Eastern on Tuesday, December 8, 2009. Executives and guests of BioTime will also be at the ceremony
StreetInsider.com  Nov 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/BioTime+%28BTIM%29+Posts+Q3+Loss+of+%240.11%2C+Wider+YY%3B+Revs+Higher/5138268.html for the full story.
Business Wire  Nov 24  Comment 
BioTime, Inc. (NYSE Amex:BTIM) reported financial results for the quarter ended September 30, 2009 and an update. For the three months ended September 30, 2009, BioTime's total quarterly revenue (including royalty income, revenue recognition of
Marketwire  Oct 23  Comment 
LOS ANGELES, CA -- (Marketwire) -- 10/23/09 -- Biotech and science of stem cells, cryogenic storage, executive pay, mortgage debt to income ratios, Forex, domestic oil production; this week on MoneyTV, hosted by anchor Donald Baillargeon. MoneyTV is



Thank you for your suggestion
RELATED WIKI ARTICLES

Related Articles

 


BioTime, Inc. (OTCBB: BTIM), a biomedical company, develops blood plasma volume expanders and blood replacement solutions for hypothermic surgery, and organ preservation solutions and technology for use in surgery, emergency trauma treatment, and other applications. Its lead product, Hextend, is a hetastarch-based synthetic blood plasma volume expander designed to treat hypovolemia in surgery for patients with blood loss. The company was founded in 1990 and is headquartered in Alameda, California.[1]




References

  1. Yahoo Finance, BTIM.ob
Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki